Company Filing History:
Years Active: 2005
Title: David J Scanlon: Innovator in Microfabrication Technology
Introduction
David J Scanlon is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of microfabrication, particularly in the development of devices that enhance cellular manipulation. His innovative work has led to the creation of a unique patent that addresses challenges in cell injection technology.
Latest Patents
David J Scanlon holds a patent for a "Microfabricated cell injector." This device features an injection wall and a cell injection needle that projects from the wall, designed to pierce cells suspended in a fluid. The needle is securely held within a housing defined by the internal surfaces of the microfabricated cell injector. The housing includes an inlet for suspended cells to enter and an outlet for cells to exit via the cell injection needle. A cell propulsion device is integrated to propel cells towards the needle, ensuring that cells suspended in the fluid are effectively impelled towards the injection wall by the injection needle. This innovative approach has the potential to advance various applications in biotechnology and medicine.
Career Highlights
David is currently employed at AstraZeneca AB, where he continues to work on cutting-edge technologies that impact the pharmaceutical industry. His expertise in microfabrication and cell manipulation has positioned him as a valuable asset to his team and the broader scientific community.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues, including Andrew J Garman and John Robert Dodgson. These partnerships have fostered an environment of innovation and have contributed to the successful development of advanced technologies in their field.
Conclusion
David J Scanlon's contributions to microfabrication technology, particularly through his patented microfabricated cell injector, highlight his role as an influential inventor in the biotechnology sector. His work continues to pave the way for advancements in cellular manipulation and medical applications.